Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus

References

• Aydos SE, Karadağ A, Özkan T, et al. (2015). Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility. Genet Mol Res 14:6330–9.
   PubMedGoogle Scholar
• Baumeister P, Märte M, Reiter M, et al. (2012). EGFR and P-GP expression in oropharyngeal mucosa in relation to smoking. Anticancer Res 32:1639–48.
   PubMed Web of Science ®Google Scholar
• Dessilly G, Panin N, Elens L, et al. (2016). Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib. Sci Rep 6:1–9.
   PubMed Web of Science ®Google Scholar
• Dickens D, Owen A, Alfirevic A, Pirmohamed M. (2013). ABCB1 single nucleotide polymorphisms (1236C > T, 2677G > T, and 3435C > T) do not affect transport activity of human P-glycoprotein. Pharmacogenet Genomics 23:314–23.
   PubMed Web of Science ®Google Scholar
• Dirks NL, Huth B, Yates CR, Meibohm B. (2004). Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. Int J Clin Pharmacol Ther 42:701–18.
   PubMed Web of Science ®Google Scholar
• Fung KL, Pan J, Ohnuma S, et al. (2014). MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stableepithelial monolayer. Cancer Res 74:598–608.
   PubMed Web of Science ®Google Scholar
• Gabardi S, Tullius SG, Krenzien F. (2015). Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly. Curr Opin Organ Transplant 20:424–30.
   PubMed Web of Science ®Google Scholar
• Gotthardt DN, Bruns H, Weiss KH, Schemmer P. (2014). Current strategies for immunosuppression following liver transplantation. Langenbecks Arch Surg 399:981–8.
   PubMed Web of Science ®Google Scholar
• Karaźniewicz-Łada M, Danielak D, Rubiś B, et al. (2015). Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites. J Clin Pharm Ther 40:226–31.
   PubMed Web of Science ®Google Scholar
• Kawauchi S, Nakamura T, Miki I, et al. (2014). Downregulation of CYP3A and P-glycoprotein in the secondary inflammatory response of mice with dextran sulfate sodium-induced colitis and its contribution to cyclosporine A blood concentrations. J Pharmacol Sci 124:180–91.
   PubMed Web of Science ®Google Scholar
• Kim TE, Lee H, Lim KS, et al. (2014). Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers. Br J Clin Pharmacol 78:556–64.
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C, Oh JM, Kim IW, et al. (2007). A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–8.
   PubMed Web of Science ®Google Scholar
• Lee J, Huang H, Chen Y, Lu X. (2014). ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients. Biopharm Drug Dispos 35:164–72.
   PubMed Web of Science ®Google Scholar
• Mikkaichi T, Yoshigae Y, Masumoto H, et al. (2014). Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition. Drug Metab Dispos 42:520–8.
   PubMed Web of Science ®Google Scholar
• Naito T, Mino Y, Aoki Y, et al. (2015). ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis. Clin Chim Acta 445:79–84.
   PubMed Web of Science ®Google Scholar
• Peng R, Zhang H, Zhang Y, Wei DY. (2016). Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs. Xenobiotica 46:948–52.
   PubMed Web of Science ®Google Scholar
• Qin XL, Chen X, Zhong GP, et al. (2014). Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. Phytomedicine 21:766–72.
   PubMed Web of Science ®Google Scholar
• Ray A, Tennakoon L, Keller J, et al. (2015). ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. Pharmacogenomics J 15:332–9.
   PubMed Web of Science ®Google Scholar
• Rychlik-Sych M, Barańska M, Dudarewicz M, et al. (2018). Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid. Arch Dermatol Res 310:515–22.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lázaro I, Herrero MJ, Jordán-De Luna C, et al. (2015). Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation. Pharmacogenomics 16:971–9.
   PubMed Web of Science ®Google Scholar
• Senarathna SM, Crowe A. (2015). The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport. Pharmazie 70:798–803.
   PubMed Web of Science ®Google Scholar
• Sy SK, Heuberger J, Shilbayeh S, et al. (2013). A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. AAPS J 15:1189–99.
   PubMed Web of Science ®Google Scholar
• Tang SC, Sparidans RW, Cheung KL, et al. (2014). Glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood disposition of the mTOR Inhibitor everolimus (Afinitor) in mice. Clin Cancer Res 20:3133–45.
   PubMed Web of Science ®Google Scholar
• Taylor AL, Watson CJ, Bradley JA. (2005). Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 56:23–46.
   PubMed Web of Science ®Google Scholar
• Togashi M, Niioka T, Komatsuda A, et al. (2015). Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. Eur J Clin Pharmacol 71:1091–7.
   PubMed Web of Science ®Google Scholar
• Ueda K, Cardarelli C, Gottesman MM, Pastan I. (1987). Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. PNAS 84:3004–8.
   PubMed Web of Science ®Google Scholar
• Vafadari R, Bouamar R, Hesselink DA, et al. (2013). Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. Ther Drug Monit 35:459–65.
   PubMed Web of Science ®Google Scholar
• Wang D, Sadée W. (2006). Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J 8:E515–20.
   PubMed Web of Science ®Google Scholar
• Weber LT. (2015). Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol 30:253–65.
   PubMed Web of Science ®Google Scholar
• Yoo HD, Lee YB. (2011). Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes. Arch Pharm Res 34:1817–28.
   PubMed Web of Science ®Google Scholar
• Zhao T, Yang C, Qiu Y, et al. (2013). Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study. Transplant Proc 45:148–52.
   PubMed Web of Science ®Google Scholar